ILEX Oncology raises $10.9 mil. in private placement financing; spin-off of non-profit cancer center.
Executive Summary
ILEX ONCOLOGY RAISES $10.9 MIL. IN ITS FIRST PRIVATE PLACEMENT FINANCING, with major investors including Hambro America Biosciences, Advent International, Boston Capital Ventures, Bioven Partners, McCombs Enterprises, Trinity University and Upjohn, the company announced Oct. 2. ILEX' mission is to "expedite the development, approval and commercialization of anticancer agents" in collaboration with partners.